For the year ending 2025-12-31, STTK had -$3,195K decrease in cash & cash equivalents over the period. -$39,953K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -48,809 |
| Stock-based compensation | 6,995 |
| Depreciation | 3,688 |
| Non-cash operating lease expense | 506 |
| Impairment loss of fixed assets | 81 |
| Non-cash license revenue | 1,000 |
| Net amortization of investments | 453 |
| Gain on lease modification | 105 |
| Prepaid expenses and other current assets | -1,818 |
| Other assets | -79 |
| Accounts payable | -318 |
| Accrued expenses and other current liabilities | -1,442 |
| Non-current operating lease liabilities | -922 |
| Net cash used in operating activities | -39,882 |
| Sales and maturities of investments | 35,600 |
| Purchases of investments | 43,416 |
| Purchase of property and equipment | 71 |
| Net cash used in investing activities | -7,887 |
| Proceeds from sale of common stock, pre-funded warrants and common stock warrants, net of offering costs | 44,475 |
| Proceeds from the exercise of common stock warrants | 139 |
| Proceeds from the exercises of stock options and purchases pursuant to employee stock purchase plan | 25 |
| Taxes paid related to net share settlement of equity awards | 65 |
| Net cash provided by financing activities | 44,574 |
| Decrease in cash and cash equivalents | -3,195 |
| Cash and cash equivalents, beginning of period | 57,387 |
| Cash and cash equivalents, end of period | 54,192 |
Shattuck Labs, Inc. (STTK)
Shattuck Labs, Inc. (STTK)